Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.
-
Published:2024-02
Issue:
Volume:965
Page:176196
-
ISSN:0014-2999
-
Container-title:European Journal of Pharmacology
-
language:en
-
Short-container-title:European Journal of Pharmacology
Author:
Tang Xiaowen,
Liao Qi,
Li Qinqin,
Jiang Linshan,
Li Wei,
Xu Jie,
Xiong Aizhen,
Wang RufengORCID,
Zhao Jing,
Wang ZhengtaoORCID,
Ding LiliORCID,
Yang Li
Reference34 articles.
1. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression;Bhummaphan;Phytomedicine,2019
2. Transcriptional Regulation of metabolic pathways via lipid-sensing nuclear receptors PPARs, FXR, and LXR in NASH;Cariello;Cell Mol. Gastroenterol. Hepatol.,2021
3. Bile acid control of metabolism and inflammation in obesity, type 2 Diabetes, dyslipidemia, and non-alcoholic fatty liver disease;Chávez-Talavera;Gastroenterology,2017
4. Validation of non-alcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD;Chen;Eur. J. Gastroenterol. Hepatol.,2023
5. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption;Clifford;Cell Metabol.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献